Resultat Typ

Sie suchten nach:

53  Ergebnisse wurden gefunden

Downstream purification for gene therapy

Downstream purification for gene therapy With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used successfu...

Purification

Purification Produktauswahl Tris and biobuffers pH adjusters (acid) pH adjusters (base) Salts Chromatography media Cleaning reagents

Avantor Production Chemicals

Avantor Production Chemicals Find everything you need for your biopharmaceutical production process. From purification to formulation and finish Avantor has it all. Fermentation and Cell Culture All additives such as amino acids minerals and vitam...

(Microsoft PowerPoint - Pr\344sentation VWR ChromJournal_Chromolith WP Epoxy-Immobilization_062018-v

(Microsoft PowerPoint - Pr\344sentation VWR ChromJournal_Chromolith WP Epoxy-Immobilization_062018-vs2_BP \(005\).PPTX [Read-Only]) Benjamin Peters Tom Kupfer Gisela Jung Peter Knoell Egidijus Machtejevas Petra Lewits Juni 2018 via immobilization ...

Upstream Gene Therapy Products & Solutions in Bioprocessing

Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...

Montreal Manufacturing Facility

Montreal Manufacturing Facility The off-loading manifold at our Montreal QC manufacturing facility which includes 8600 sq. ft. for manufacturing 2200 sq. ft. for quality control and a 22800 sq. ft. warehouse. Core Capabilities Production of labora...

Downstream purification for recombinant proteins

Downstream purification for recombinant proteins With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used s...

Final fill for cell therapy

Final fill for cell therapy The cell therapy drug product is configured in different ways depending on the required delivery of the cells/tissues. For example delivery of chondrocytes for cartilage repair is administered by an injection. Expanded ...

Upstream processing for cell therapy

Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...

Improve Your Biochromatography Separations - How to Optimize your Charge Variant Analysis

Improve Your Biochromatography Separations - How to Optimize your Charge Variant Analysis Webinar Thursday November 7th 2019 15:00 to 16:00 CEST (Berlin Paris Madrid) PRESENTED IN ENGLISH Replay Email Alerts Free Registration Chat Area Certificate...

Final fill for mAbs

Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...

Final fill for vaccines

Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...

Microsoft Word - Grades.docx

Microsoft Word - Grades.docx Definitions of J.T.Baker® Grades and Macron Fine Chemicals™ Grades J.T.Baker® Grades BAKER ANALYZED™ Reagent—A grade of high quality chemicals for laboratory and specialized industrial use. Every BAKER ANALYZED™ Reagen...

Upstream processing for mAbs

Upstream processing for mAbs Developing and manufacturing mAbs has moved away from a dependency on raw materials of animal origin. Our biochemical components and supplements are animal component-free to meet the needs of these applications. Produc...

~~29188433AA Production of recombinant monoclonal an~~

1.0 0.9 0.8 0.7 0.6 0.5 rM A b (g /L ) 0.4 0.3 0.2 0.1 0 10 9 8 7 6 5 C el l d en si ty (c el ls /m L) 4 3 2 1 0 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Time (d) Feed Application note 29188433 AA GE Healthcare Production of recombinant monoclonal antib...

Aurora Manufacturing Facility

Aurora Manufacturing Facility Our 65000 sq. ft. manufacturing facility in Aurora OH USA includes a 12000 sq. ft. excipient processing center 3000 sq. ft. for repackaging 35000 sq. ft. warehouse 8000 sq. ft. office 8000 sq. ft. manufacturing area a...
1 - 16 of 53